FMC-1807-PDX-bearing mice were intraperitoneally injected with CD63-GFP-expressing EV and sacrificed at 12- or 24-h post-injection to detect the cellular uptake of EV in multiple tissues, including the primary tumor, lung, liver, spleen and kidney. Here, CD63 is linked to neoplasm.